New #JITC article: Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma bit.ly/3ytq3tn Arianna Draghi Marco Donia

New #JITC review: Immunotherapy in the neoadjuvant treatment of gastrointestinal tumors: is the time ripe? bit.ly/3yuAUU2 Lorenzo Gervaso, MD

New #JITC article: Exosomal circPOLQ promotes macrophage M2 polarization via activating IL-10/STAT3 axis in a colorectal cancer model bit.ly/4bwQa12

SITC NEEDS YOUR HELP! “SCION commentary on measurement and interpretation of essential biomarkers in early clinical trials” manuscript recently published in Journal for ImmunoTherapy of Cancer. We invite feedback on the proposed process & prioritization framework. Take the survey: surveymonkey.com/r/KGPQSMG

New #JITC article: Enhancing IgA-mediated neutrophil cytotoxicity against neuroblastoma by CD47 blockade bit.ly/3UTRZhx Jeanette Leusen

New #JITC article: Developing a membrane-proximal CD33-targeting CAR T cell bit.ly/4axe0IG Ruby Freeman Sanam Shahid Serena Mathew @ssouness Erin Burns Jasmine Um Kinga Ross Levine Jaap J Boelens Anthony Daniyan Renier Brentjens

New #JITC article: Sequence of androgen receptor-targeted vaccination with androgen deprivation therapy affects anti-prostate tumor efficacy bit.ly/3WOj744 Anusha Muralidhar

Heading to #ASCO24 ? Meet #JITC Incoming Editor-in-Chief Dr. Michael T. Lotze at the SITC booth (12040) on Sunday, June 2 / 12:00 – 1:00pm CT. He will be available to take questions and hear about your research/publication interests.